iSchemaView (AKA RapidAI)

What iSchemaView (AKA RapidAI) does

iSchemaView, Inc. (operating commercially as RapidAI) is a San Francisco-headquartered clinical AI software company founded by Greg Albers, MD. The company develops and sells an enterprise clinical AI platform that connects medical imaging to clinical action across hospital systems. Its product portfolio comprises 30 FDA-cleared AI modules spanning neurovascular (ischemic stroke, neurocritical assessment including ICH/SDH/MLS, aneurysm detection and longitudinal tracking), cardiac and vascular (aortic assessment, pulmonary embolism detection and severity stratification), and radiology workflows (Navigator Pro for case prioritization, AI interpretation assistance, and auto-reporting). Supporting products include Lumina 3D (advanced 3D visualization, recognized by TIME as a Best Invention of 2025), the Rapid Mobile App (real-time care team collaboration and notifications), Rapid Insights (performance and utilization analytics), Rapid U (professional education), Edge Cloud (deployment infrastructure), and a Life Sciences offering for imaging biomarker automation, patient identification, and trial analytics. The platform integrates natively with EHR and PACS systems and operates as a vendor-agnostic enterprise stack.

RapidAI operates a direct enterprise field sales motion targeting large hospital systems and academic medical centers, with a quote-based, annual subscription pricing model tailored to each health system's scale and module footprint. Implementation support and professional education are delivered alongside platform deployment. The platform is deployed across 2,500+ hospitals in 100+ countries, processes over 20,000 daily scans, and is supported by 750+ peer-reviewed publications including 11 in the New England Journal of Medicine. Named enterprise customers include Mayo Clinic, Stanford Health Care, HCA Healthcare, Ascension, CommonSpirit Health, Providence, Intermountain Health, Corewell Health, Atrium Health, Trinity Health, University of Chicago Medicine, OSF Healthcare, UF Health, UnityPoint Health, El Camino Health, and Stony Brook University. Revenue is not publicly disclosed; the company is a privately held, venture-backed entity with no identified parent, subsidiary, or public listing.

Name

iSchemaView (AKA RapidAI)

Legal name

iSchemaView, Inc.

Website

https://ischemaview.com

Company type

Private

Operating status

Operating

Short description

RapidAI is a San Francisco-based clinical AI company that sells an enterprise platform of 30 FDA-cleared imaging AI modules for stroke, neurocritical, cardiac, vascular, and radiology workflows, deployed across 2,500+ hospitals in 100+ countries.

Ownership category

akta.pro rank

Product category

Clinical Imaging AI

NAICS

Computer Systems Design and Related Services (54151)

akta.pro primary industry

Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ)

akta.pro secondary industries

SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG), AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG), Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity) (HLACABAM)

Keywords

• Clinical imaging AI
• Stroke imaging AI
• Radiology decision support
• Neurovascular imaging
• Medical imaging analytics

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

1. Enterprise Platform Subscription: Annual or multi-year subscription for clinical AI platform deployment across hospital systems. Includes FDA-cleared AI modules, workflow integration, enterprise infrastructure, and analytics capabilities deployed across service lines.
2. Professional Services & Implementation: Implementation support, hands-on workflow optimization, and professional education services (Rapid U) delivered alongside platform deployment.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels10 records

Core offering

iSchemaView, Inc. (operating as RapidAI) develops and sells a clinical AI platform that connects medical imaging to clinical action across hospital systems. The platform delivers FDA-cleared AI modules for neurovascular, cardiac, vascular, and radiology imaging, integrated directly with EHR and PACS workflows. Offerings include solutions for ischemic stroke, aneurysm, neurocritical care, aortic assessment, pulmonary embolism, radiology workflow (Navigator Pro), life sciences clinical trials, mobile collaboration, 3D visualization (Lumina 3D), analytics (Rapid Insights), and professional education (Rapid U).

Product overview

RapidAI offers a unified clinical AI enterprise platform (Rapid Enterprise Platform) that connects medical imaging to clinical action across health systems. The platform operates a modular architecture with specialized solutions for Neurovascular (Neurocritical, Ischemic Stroke, Aneurysm), Cardiac & Vascular (Aortic, Pulmonary Embolism), and Radiology (Navigator Pro). Supporting products include the Rapid Mobile App for real-time collaboration, Rapid Insights for analytics, Lumina 3D for advanced visualization, Life Sciences for clinical trials, and Rapid U for professional education. All 30 FDA-cleared modules share the core platform infrastructure with workflow integration to EHR/PACS systems and data analytics capabilities.

Differentiator

Problem solved

Functional benefit

Brands

• Rapid Enterprise Platform: The enterprise platform connecting imaging to clinical action across health systems
• Navigator Pro
• Rapid Insights
• Rapid U
• Radiology Rewired
• Lumina 3D
• Edge Cloud

Products and services

• Rapid Enterprise Platform The core enterprise platform connecting medical imaging to clinical action across the health system, enabling cross-disciplinary deployment of deep clinical AI with workflow integration, enterprise infrastructure, and data analytics capabilities. Sold to hospitals, health systems, and academic medical centers.
• Navigator Pro Radiology's AI interface providing case prioritization, AI interpretation assistance, auto-reporting, and care team connectivity for streamlined diagnostic workflows. Built for radiologists and radiology departments.
• Neurocritical Suite of tools for neurocritical assessment covering intracerebral hemorrhage (ICH) with hyperdensity, subdural hematoma (SDH), midline shift (MLS), and DeltaFuse advanced imaging analysis. Used by neurocritical care, neurology, and emergency teams.
• Ischemic Stroke Solution Complete ischemic stroke solution spanning the patient journey from non-contrast CT (NCCT), CT angiography (CTA), CT perfusion (CTP), through intervention support. Sold to stroke centers, hospitals, and neurovascular teams.
• Aneurysm AI-driven aneurysm detection with growth assessment capabilities and longitudinal tracking for rupture risk stratification in cerebral aneurysms. Used by neurosurgery, neurovascular, and radiology teams.
• Aortic Automated measurements and 3D renderings for comprehensive aortic assessment and surveillance workflows. Used by cardiac, vascular, and radiology teams managing aortic disease.
• Pulmonary Embolism (Rapid PE) AI-powered suspected and incidental pulmonary embolism detection with severity stratification for faster clinical decision-making. Used by emergency, radiology, and pulmonary teams.
• Life Sciences Imaging biomarker automation, patient identification, and trial analytics solutions supporting clinical trial enrollment and research workflows for life sciences and pharmaceutical organizations.
• Rapid Mobile App Mobile application delivering real-time collaboration, notifications for urgent cases, DICOM viewer access, in-app messaging, and EMR integration to support care coordination across emergency, radiology, and operating room teams.
• Rapid Insights Custom performance analytics platform providing visibility into performance metrics, utilization data, and clinical impact across service lines for hospital administrators and clinical leadership.
• Lumina 3D Advanced AI-powered 3D imaging visualization and rendering technology for enhanced anatomical visualization, named to TIME's List of the Best Inventions of 2025.
• Rapid U Professional education platform delivering immersive educational experiences for clinical users on the RapidAI platform.

Quantifiable outcome

• 2,500+ hospitals served globally
• +4 more outcomes

Named customers16 records

Segments7 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature15 records

Partnerships

Two partnerships are on record, tiered core.

• EHR SystemscoreTechnology or IntegrationRapidAI integrates with Electronic Health Record (EHR) systems as part of its enterprise workflow integration capability. The platform connects imaging data to clinical action within existing EHR workflows, enabling seamless clinical execution and real-time patient case summaries with EMR integration.
• PACS (Picture Archiving and Communication Systems)coreTechnology or IntegrationRapidAI integrates with PACS systems to deliver AI outputs and imaging analysis directly within radiologists' existing viewing workflows. The platform provides vendor-agnostic integration ensuring broad compatibility across different PACS environments.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Viz.ai: Viz.ai is a direct competitor in AI-powered stroke and neurovascular imaging coordination, offering AI triage and care team workflow tools very similar to RapidAI's Ischemic Stroke and Neurocritical solutions.
• DeepHealth (by RadNet): DeepHealth is a digital health AI subsidiary of RadNet offering FDA-cleared imaging AI for mammography, prostate, and chest, comparable as a vendor of cleared radiology AI modules sold to clinical sites.
• Icometrix: Icometrix provides AI-based brain imaging analysis for multiple sclerosis, dementia, and traumatic brain injury, overlapping with RapidAI's neurocritical and longitudinal tracking capabilities.
• Brainomix: Brainomix develops AI imaging software for stroke and neurovascular assessment (e.g., e-Stroke), directly competing with RapidAI in the ischemic stroke imaging workflow.
• Avicenna.ai: Avicenna.ai builds AI for medical imaging including stroke and pulmonary embolism triage, directly competing with RapidAI's PE detection and neurovascular modules.
• Aidoc: Aidoc is a direct competitor in enterprise radiology AI triage and worklist prioritization, with overlapping hospital-system customer base and similar FDA-cleared imaging AI modules.

Emerging players

• Annalise.ai: Annalise.ai offers comprehensive AI for chest X-ray and other radiology workflows, with comparable enterprise imaging AI positioning though earlier-stage commercialization relative to RapidAI.

Broad incumbents

• GE HealthCare: GE HealthCare is a broad incumbent in medical imaging equipment and PACS, with its own Edison AI platform bundling imaging AI directly into modalities and viewing workflows where RapidAI integrates.
• Siemens Healthineers: Siemens Healthineers provides imaging hardware, PACS, and AI-powered radiology applications (AI-Rad Companion), representing a broad incumbent that competes and partners with RapidAI across enterprise imaging stacks.
• Philips Healthcare: Philips offers enterprise imaging informatics, PACS, and AI-enabled clinical applications as part of a broad portfolio, comparable as a large incumbent that could bundle imaging AI against standalone vendors like RapidAI.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/rapidai
• YouTubeyoutube.com/@RapidAIEnterprise
• LinkedInlinkedin.com/company/rapid-ai

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about iSchemaView (AKA RapidAI)